VectorisBio
VectorisBio is a biotechnology company harnessing artificial intelligence to advance chromatography technology for viral vectors.
We apply AI-driven molecular design and docking to engineer novel affinity ligands, enabling more precise, efficient, and scalable purification platforms for complex biologics, including viral vectors and vaccine products.
Our platform accelerates ligand discovery by rapidly exploring chemical space and predicting target interactions with high accuracy. This data-driven approach, combined with deep expertise in ligand chemistry, chromatography, and downstream process design, allows us to deliver purification solutions tailored to the evolving needs of modern therapeutics.
For biotechs, CDMOs, and academic labs, our technology means higher yields, greater purity, and faster development timelines in viral vector production — ultimately making advanced therapies more accessible and affordable.
Image depicting a modelled synthetic ligand (ligand VB11a) binding VSV-G envelope protein.
Vision
We envision a future where artificial intelligence and biotechnology converge to set new standards in viral vector purification. By applying AI-driven molecular design and docking, we aim to create purification technologies that are not only faster and more precise, but also adaptable to the rapidly evolving needs of advanced therapies.
Our vision extends beyond incremental improvements — we seek to redefine the foundations of downstream bioprocessing, turning today’s bottlenecks into tomorrow’s breakthroughs. We see a world where scalable and affordable purification platforms empower innovators to bring novel cell and gene therapies to patients without delay, regardless of geography or resources.
Mission
At VectorisBio, our mission is to transform viral vector purification through AI-driven molecular design and docking. We develop next-generation synthetic ligands and chromatography platforms that deliver higher yields, greater purity, and faster production timelines. By combining advanced computation with deep expertise in chemistry and process engineering, we empower biotechs, CDMOs, and academic labs to accelerate the development of life-changing cell and gene therapies.